Published August 2013 Update expected: Late 2018/Early 2019 Read Executive Summary Read Full-Text Guideline
This collaborative guideline developed recommendations on several questions related to appropriate use of radiation therapy (RT) in patients who have undergone prostatectomy, both as adjuvant therapy following surgery and after recurrence. It examines the impact of adjuvant RT on recurrence and survival and how these outcomes are affected by factors such as margin status, seminal vesicle invasion, Gleason score and patient age. For salvage therapy, the guideline also addresses whether RT improves outcomes and whether its effects are limited to certain patient subgroups. In addition, the document considers the question of whether to administer adjuvant RT prior to recurrence or wait and treat patients who recur with salvage RT. Finally, RT techniques, use of androgen deprivation therapy together with RT, and data on toxicity and quality of life in the post-prostatectomy setting are discussed.
Developed in collaboration with:
Endorsed by: American Society of Clinical Oncology Key Points:
Resources: Challenging Cases in the Management of Newly Diagnosed and Recurrent Prostate Cancer (CME)
We have recently updated our privacy policy and terms of use. By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use. We use cookies to provide, secure and improve our services to you. To learn more, click here.